… Erlotinib induced gastrointestinal bleeding is rare, and dose-related. We are reporting a
lung cancer patient who received erlotinib and gefitinib. The patient was sensitive to drug and …

… erlotinib and gefitinib had similar effectiveness but gefitinib had a better safety profile compared
to erlotinib… the prevalence of patients taking erlotinib and gefitinib for treating NSCLC in …

… patients treated with first-line afatinib, gefitinib, or erlotinib for … inferiority of gefitinib in terms
of PFS compared with erlotinib [… afatinib with gefitinib as a first-line treatment in patients with …

… prior gefitinib therapy and with subsequent erlotinib treatment … from erlotinib identified was
previous response to gefitinib. … potential benefit from erlotinib use in this patient population is …

… in patients treated with erlotinib and carboplatin/paclitaxel in comparison with those treated
… In colorectal cancer, single-agent treatment with TKIs (erlotinib, gefitinib) seems to be able …

… Patients treated with erlotinib showed better cytologic conversion rate of LMC than those with
gefitinib (64.3% [9 of 14] in the erlotinib … to assess efficacies of erlotinib and gefitinib in the …

… of erlotinib and gefitinib in previously treated NSCLC patients. … (probability) for receiving
erlotinib or gefitinib treatment from a … potential confounders in selecting erlotinib and gefitinib 18. …

… efficacy than gefitinib or erlotinib in first-line treatment of EGFR-… more effective than erlotinib
as second-line treatment of patients with … to that of erlotinib but higher than that of gefitinib. …

… no patient was identified whose death was attributed to treatment with erlotinib or gefitinib. …
for the first time that adjuvant therapy with erlotinib or gefitinib in patients with resected lung …

… Thus, at this point, patients whose tumors test negative for EGFR mutations should not
necessarily be precluded from treatment with either gefitinib or erlotinib. Data presented here …